Mayinglong Pharmaceutical Group Co Ltd (600993) — Free Cash Flow Generation Index
Mayinglong Pharmaceutical Group Co Ltd (600993) has a Free Cash Flow Generation Index of 1.10x as of September 2025. Free cash flow of CN¥152.93 Million represents 1% of operating cash flow (CN¥139.20 Million). See working capital position of Mayinglong Pharmaceutical Group Co Ltd to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Mayinglong Pharmaceutical Group Co Ltd Free Cash Flow Generation Index (2003–2025)
Historical FCF Generation Index trend for Mayinglong Pharmaceutical Group Co Ltd across 22 annual periods. Explore Mayinglong Pharmaceutical Group Co Ltd (600993) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Mayinglong Pharmaceutical Group Co Ltd (2003–2025)
Year-by-year Free Cash Flow Generation Index for Mayinglong Pharmaceutical Group Co Ltd. For the full company profile including market capitalisation, see market value of Mayinglong Pharmaceutical Group Co Ltd.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.80x | CN¥481.07 Million | CN¥600.44 Million | CN¥119.37 Million | ▲ +35.7% |
| 2024 | 0.59x | CN¥293.76 Million | CN¥497.61 Million | CN¥203.85 Million | ▲ +0.3% |
| 2023 | 0.59x | CN¥355.70 Million | CN¥604.07 Million | CN¥248.36 Million | ▼ -24.6% |
| 2022 | 0.78x | CN¥266.84 Million | CN¥341.85 Million | CN¥75.01 Million | ▼ -12.4% |
| 2021 | 0.89x | CN¥532.07 Million | CN¥597.17 Million | CN¥65.10 Million | ▲ +6.1% |
| 2020 | 0.84x | CN¥237.58 Million | CN¥282.99 Million | CN¥45.41 Million | ▼ -7.3% |
| 2019 | 0.91x | CN¥445.23 Million | CN¥491.58 Million | CN¥46.36 Million | ▼ -1.4% |
| 2018 | 0.92x | CN¥283.28 Million | CN¥308.24 Million | CN¥24.96 Million | ▲ +4.2% |
| 2017 | 0.88x | CN¥314.26 Million | CN¥356.17 Million | CN¥41.91 Million | ▲ +21.2% |
| 2016 | 0.73x | CN¥174.36 Million | CN¥239.60 Million | CN¥65.24 Million | ▲ +125.8% |
| 2015 | 0.32x | CN¥58.92 Million | CN¥182.85 Million | CN¥123.93 Million | ▲ +649.9% |
| 2014 | 0.04x | CN¥4.80 Million | CN¥111.67 Million | CN¥106.87 Million | ▼ -87.9% |
| 2013 | 0.36x | CN¥46.26 Million | CN¥129.94 Million | CN¥83.68 Million | ▼ -55.9% |
| 2012 | 0.81x | CN¥136.50 Million | CN¥169.25 Million | CN¥32.75 Million | ▲ +98.2% |
| 2011 | 0.41x | CN¥30.67 Million | CN¥75.37 Million | CN¥44.69 Million | ▼ -51.5% |
| 2009 | 0.84x | CN¥181.18 Million | CN¥216.11 Million | CN¥34.93 Million | ▲ +23.3% |
| 2008 | 0.68x | CN¥69.75 Million | CN¥102.59 Million | CN¥32.84 Million | ▲ +124.3% |
| 2007 | -2.80x | CN¥-18.16 Million | CN¥6.49 Million | CN¥24.65 Million | ▼ -490.7% |
| 2006 | 0.72x | CN¥53.95 Million | CN¥75.27 Million | CN¥21.32 Million | ▲ +86.3% |
| 2005 | 0.38x | CN¥22.49 Million | CN¥58.43 Million | CN¥35.95 Million | ▼ -17.4% |
| 2004 | 0.47x | CN¥25.25 Million | CN¥54.19 Million | CN¥28.94 Million | ▼ -40.6% |
| 2003 | 0.78x | CN¥52.98 Million | CN¥67.52 Million | CN¥14.54 Million | — |